Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca to cut 8,000 jobs

Anglo-Swedish pharmaceutical giant, AstraZeneca is to cut 8,000 jobs worldwide by 2014

Anglo-Swedish pharmaceutical giant, AstraZeneca (AZ) has announced it is to cut 8,000 jobs worldwide by 2014.

AZ, which employs 11,000 people in the UK, including offices in London, Macclesfield, Cheshire, Luton and Bristol, has yet to say how the job cuts will affect the UK.

The cuts come on top of 12,600 job losses since 2007 as the firm continues to further its 'productivity programmes' which have already saved $1.6bn. AZ has predicted a further $1.8bn to be saved over the next four years with this latest announcement.

The losses will come in the firm's sales and marketing, business infrastructure, research and development, and supply chain operations, as AZ looks to focus on its more profitable drugs and treatment departments.

There was also a warning that some research and development sites could be closed.

The news comes as AZ announced a "strong financial performance in 2009" which saw the firm's annual revenues increase by seven per cent, as well as the elimination of its $7,174m net debt.

28th January 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...